Teva Pharmaceutical Industries Limited
TEVA
$18.46
-$0.34-1.81%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.16B | 1.70B | 3.30B | 3.32B | 2.26B |
| Total Receivables | 3.56B | 3.38B | 3.06B | 3.46B | 3.77B |
| Inventory | 3.50B | 3.25B | 3.01B | 3.96B | 3.93B |
| Prepaid Expenses | 1.08B | 1.02B | 1.01B | 1.13B | 1.10B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.31B | 2.18B | 2.18B | 447.00M | 585.00M |
| Total Current Assets | 12.62B | 11.53B | 12.55B | 12.31B | 11.63B |
|
|
|||||
| Total Current Assets | 12.62B | 11.53B | 12.55B | 12.31B | 11.63B |
| Net Property, Plant & Equipment | 5.17B | 4.99B | 4.95B | 6.04B | 5.93B |
| Long-term Investments | 15.95B | 15.48B | 15.15B | 16.12B | 16.49B |
| Goodwill | 15.95B | 15.48B | 15.15B | 16.12B | 16.49B |
| Total Other Intangibles | 4.14B | 4.19B | 4.42B | 4.76B | 4.85B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.25B | 2.23B | 2.26B | 2.53B | 2.43B |
| Total Assets | 40.13B | 38.42B | 39.33B | 41.76B | 41.34B |
|
|
|||||
| Total Accounts Payable | 2.50B | 2.29B | 2.20B | 2.37B | 2.37B |
| Total Accrued Expenses | 6.05B | 5.71B | 5.65B | 5.98B | 5.64B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 464.00M | 421.00M | 1.87B | 2.58B | 2.09B |
| Total Finance Division Other Current Liabilities | 2.85B | 2.74B | 3.07B | 2.86B | 2.94B |
| Total Other Current Liabilities | 2.85B | 2.74B | 3.07B | 2.86B | 2.94B |
| Total Current Liabilities | 11.86B | 11.16B | 12.80B | 13.80B | 13.04B |
|
|
|||||
| Total Current Liabilities | 11.86B | 11.16B | 12.80B | 13.80B | 13.04B |
| Long-Term Debt | 16.78B | 16.23B | 16.00B | 16.40B | 16.55B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 296.00M | 288.00M | 314.00M | 295.00M | 281.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.36B | 4.47B | 4.49B | 4.88B | 4.91B |
| Total Liabilities | 33.30B | 32.15B | 33.61B | 35.37B | 34.78B |
|
|
|||||
| Common Stock & APIC | 28.06B | 28.02B | 27.82B | 27.92B | 27.89B |
| Retained Earnings | -14.68B | -14.96B | -15.17B | -14.96B | -14.52B |
| Treasury Stock & Other | -6.56B | -6.80B | -7.28B | -6.90B | -7.01B |
| Total Common Equity | 6.83B | 6.26B | 5.37B | 6.07B | 6.36B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.83B | 6.26B | 5.37B | 6.07B | 6.36B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 7.00M | 7.00M | 347.00M | 319.00M | 204.00M |
| Total Equity | 6.83B | 6.27B | 5.72B | 6.38B | 6.56B |
|
|
|||||